Moreover, in a mouse model of NK cell-deficient AD (AD-like disease induced in Il15−/− mice by application of MC903), the reduction in NK cell numbers was restored by dupilumab as a Th2 cytokine blocker, suggesting that NK cells may contribute to suppressing the type 2 inflammation in AD (48). This evidence concerns the gene IL15 and Alzheimer disease.